The response to initial chemotherapy as a prognostic factor in localized Ewing's sarcoma. 1985

O Oberlin, and C Patte, and F Demeocq, and M J Lacombe, and M Brunat-Mentigny, and M C Demaille, and P Tron, and B N'Guyen Bui, and J Lemerle

Ninety-five children with localized Ewing's sarcoma were included in a prospective cooperative study. All patients received initial chemotherapy with the purpose of early prevention of metastases and improvement of the conditions of the subsequent local therapy, radiotherapy in all cases, surgical resection in selected cases. Clinical response to initial chemotherapy was evaluated in 67 patients who had measurable soft tissue mass or functional symptoms. This response appeared highly correlated with outcome as the disease-free survival was 57.3% for the 41 good responders and 9% for the 26 bad responders (P less than 0.00001), though 23 of these bad responders reached complete remission with radiotherapy. This study also confirms the prognostic significance for survival of the site of the primary tumor on axial skeleton or on limbs. Nevertheless, this factor had no predictive value for response to chemotherapy, which thus appears to be an independent factor.

UI MeSH Term Description Entries
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001859 Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. Bone Cancer,Cancer of Bone,Cancer of the Bone,Neoplasms, Bone,Bone Neoplasm,Neoplasm, Bone
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D003609 Dactinomycin A compound composed of a two CYCLIC PEPTIDES attached to a phenoxazine that is derived from STREPTOMYCES parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015) Actinomycin,Actinomycin D,Meractinomycin,Cosmegen,Cosmegen Lyovac,Lyovac-Cosmegen,Lyovac Cosmegen,Lyovac, Cosmegen,LyovacCosmegen
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell

Related Publications

O Oberlin, and C Patte, and F Demeocq, and M J Lacombe, and M Brunat-Mentigny, and M C Demaille, and P Tron, and B N'Guyen Bui, and J Lemerle
April 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
O Oberlin, and C Patte, and F Demeocq, and M J Lacombe, and M Brunat-Mentigny, and M C Demaille, and P Tron, and B N'Guyen Bui, and J Lemerle
December 1985, European journal of cancer & clinical oncology,
O Oberlin, and C Patte, and F Demeocq, and M J Lacombe, and M Brunat-Mentigny, and M C Demaille, and P Tron, and B N'Guyen Bui, and J Lemerle
July 1988, International journal of radiation oncology, biology, physics,
O Oberlin, and C Patte, and F Demeocq, and M J Lacombe, and M Brunat-Mentigny, and M C Demaille, and P Tron, and B N'Guyen Bui, and J Lemerle
September 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
O Oberlin, and C Patte, and F Demeocq, and M J Lacombe, and M Brunat-Mentigny, and M C Demaille, and P Tron, and B N'Guyen Bui, and J Lemerle
August 1983, Cancer,
O Oberlin, and C Patte, and F Demeocq, and M J Lacombe, and M Brunat-Mentigny, and M C Demaille, and P Tron, and B N'Guyen Bui, and J Lemerle
October 2010, Indian journal of orthopaedics,
O Oberlin, and C Patte, and F Demeocq, and M J Lacombe, and M Brunat-Mentigny, and M C Demaille, and P Tron, and B N'Guyen Bui, and J Lemerle
September 1974, Revue de stomatologie et de chirurgie maxillo-faciale,
O Oberlin, and C Patte, and F Demeocq, and M J Lacombe, and M Brunat-Mentigny, and M C Demaille, and P Tron, and B N'Guyen Bui, and J Lemerle
January 1998, Acta oncologica (Stockholm, Sweden),
O Oberlin, and C Patte, and F Demeocq, and M J Lacombe, and M Brunat-Mentigny, and M C Demaille, and P Tron, and B N'Guyen Bui, and J Lemerle
December 1972, Cancer,
O Oberlin, and C Patte, and F Demeocq, and M J Lacombe, and M Brunat-Mentigny, and M C Demaille, and P Tron, and B N'Guyen Bui, and J Lemerle
September 2015, The West Indian medical journal,
Copied contents to your clipboard!